Search research articles
Contact Us
Filters
Showing results (31-40 of 90) with videos related to
Page
of 9
Sort By:
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1984
[High prevalence of antiHTLV-1 antibodies in the Boni, an ethnic group of African origin isolated in French Guiana since the 18th century]
A Gessain, A Calender, M Strobel, et al.
Annales D'Endocrinologie
|
April 6, 1999
[Clinicogenetic study of MEN1: recent physiopathological data and clinical applications. Study Group of Multiple Endocrine Neoplasia (GENEM)]
A Calender, S Giraud, N Porchet, et al.
European Journal of Immunology
|
December 1, 1990
Complement alternative pathway activation and control on membranes of human lymphoid B cell lines
V Caudwell, F Porteu, A Calender, et al.
Pathologica
|
March 3, 2004
New insights in genetic testing of Multiple Endocrine Neoplasia type 1 (MEN1)
A Calender, C Vercherat, B Chambe, et al.
Revue De Laryngologie - Otologie - Rhinologie
|
January 1, 1986
[Malignant lymphoma, ORL localization, and the presence of anti-HTLV-I antibodies in Martinique]
A Gessain, P Escarmant, A Jouannelle, et al.
International Journal of Cancer
|
January 15, 1989
Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase
M de Turenne-Tessier, T Ooka, A Calender, et al.
Virus Research
|
January 1, 1993
Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number
M Cordier-Bussat, A Calender, M Vuillaume, et al.
Presse Medicale (Paris, France : 1983)
|
March 18, 1995
[Hereditary multiple endocrine neoplasia. New genetic data and clinical applications in type 1 multiple endocrine neoplasia]
A Calender, S Giraud, G M Lenoir, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1987
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells
A Calender, M Billaud, J P Aubry, et al.
Lancet (London, England)
|
May 26, 1984
HTLV antibodies in patients with non-Hodgkin lymphomas in Martinique
A Gessain, A Jouannelle, P Escarmant, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 90) with videos related to
Sort By:
Page
of 9
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1984
[High prevalence of antiHTLV-1 antibodies in the Boni, an ethnic group of African origin isolated in French Guiana since the 18th century]
A Gessain, A Calender, M Strobel, et al.
Annales D'Endocrinologie
|
April 6, 1999
[Clinicogenetic study of MEN1: recent physiopathological data and clinical applications. Study Group of Multiple Endocrine Neoplasia (GENEM)]
A Calender, S Giraud, N Porchet, et al.
European Journal of Immunology
|
December 1, 1990
Complement alternative pathway activation and control on membranes of human lymphoid B cell lines
V Caudwell, F Porteu, A Calender, et al.
Pathologica
|
March 3, 2004
New insights in genetic testing of Multiple Endocrine Neoplasia type 1 (MEN1)
A Calender, C Vercherat, B Chambe, et al.
Revue De Laryngologie - Otologie - Rhinologie
|
January 1, 1986
[Malignant lymphoma, ORL localization, and the presence of anti-HTLV-I antibodies in Martinique]
A Gessain, P Escarmant, A Jouannelle, et al.
International Journal of Cancer
|
January 15, 1989
Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase
M de Turenne-Tessier, T Ooka, A Calender, et al.
Virus Research
|
January 1, 1993
Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number
M Cordier-Bussat, A Calender, M Vuillaume, et al.
Presse Medicale (Paris, France : 1983)
|
March 18, 1995
[Hereditary multiple endocrine neoplasia. New genetic data and clinical applications in type 1 multiple endocrine neoplasia]
A Calender, S Giraud, G M Lenoir, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1987
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells
A Calender, M Billaud, J P Aubry, et al.
Lancet (London, England)
|
May 26, 1984
HTLV antibodies in patients with non-Hodgkin lymphomas in Martinique
A Gessain, A Jouannelle, P Escarmant, et al.
Page
of 9